Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Tectonic Therapeutic, Inc. (TECX)

Compare
15.62
-1.05
(-6.30%)
At close: April 4 at 4:00:02 PM EDT
15.62
0.00
(0.00%)
After hours: April 4 at 4:05:07 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
58,015
58,015
44,648
32,830
15,610
Operating Income
-58,015
-58,015
-44,648
-32,830
-15,610
Net Non Operating Interest Income Expense
4,154
4,154
429
5
-445
Other Income Expense
-4,121
-4,121
1,396
645
7,128
Pretax Income
-57,982
-57,982
-42,823
-32,180
-8,927
Net Income Common Stockholders
-57,982
-57,982
-42,823
-32,180
-8,927
Diluted NI Available to Com Stockholders
-57,982
-57,982
-42,823
-32,180
-8,927
Basic EPS
-6.83
--
-2.91
-2.18
-0.61
Diluted EPS
-6.83
--
-2.91
-2.18
-0.61
Basic Average Shares
8,490.17
--
14,734.32
14,734.32
14,734.32
Diluted Average Shares
8,490.17
--
14,734.32
14,734.32
14,734.32
Total Operating Income as Reported
-58,015
-58,015
-44,648
-32,830
-15,610
Total Expenses
58,015
58,015
44,648
32,830
15,610
Net Income from Continuing & Discontinued Operation
-57,982
-57,982
-42,823
-32,180
-8,927
Normalized Income
-54,372
-54,372
-44,078
-32,823
-16,053
Interest Income
4,261
4,261
581
149
--
Interest Expense
107
107
152
144
445
Net Interest Income
4,154
4,154
429
5
-445
EBIT
-57,875
-57,875
-42,671
-32,036
-8,482
EBITDA
-56,230
-56,230
-41,193
-31,030
-8,118
Reconciled Depreciation
1,645
1,645
1,478
1,006
364
Net Income from Continuing Operation Net Minority Interest
-57,982
-57,982
-42,823
-32,180
-8,927
Total Unusual Items Excluding Goodwill
-3,610
-3,610
1,255
643
7,126
Total Unusual Items
-3,610
-3,610
1,255
643
7,126
Normalized EBITDA
-52,620
-52,620
-42,448
-31,673
-15,244
12/31/2021 - 6/21/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KROS Keros Therapeutics, Inc.
9.98
-2.92%
 
LXEO Lexeo Therapeutics, Inc.
2.3350
-11.55%
 
MLYS Mineralys Therapeutics, Inc.
12.40
-8.35%
 
CRNX Crinetics Pharmaceuticals, Inc.
26.89
-6.86%
 
CNTA Centessa Pharmaceuticals plc
11.68
-10.57%
 
TRVI Trevi Therapeutics, Inc.
6.05
-2.73%
 
SRRK Scholar Rock Holding Corporation
26.90
-12.38%
 
MLTX MoonLake Immunotherapeutics
37.21
-2.23%
 
VERA Vera Therapeutics, Inc.
21.31
-6.29%
 
NKTR Nektar Therapeutics
0.5519
-8.09%